Opus Point Partners Management’s Axsome Therapeutics AXSM Stock Holding History

Opus Point Partners Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-120,150	Closed	-$415K	–	42
2018 Q3	$415K	Sell	120,150 -13,350	-10%	-$39.6K	0.99%	30
2018 Q2	$427K	Hold	133,500	–	–	0.93%	28
2018 Q1	$327K	Hold	133,500	–	–	0.69%	34
2017 Q4	$748K	Hold	133,500	–	–	0.79%	37
2017 Q3	$741K	Hold	133,500	–	–	0.73%	37
2017 Q2	$734K	Sell	133,500 -133,500	-50%	-$559K	0.82%	39
2017 Q1	$1.04M	Buy	+267,000	New	+$1.28M	0.83%	35

Other funds holding AXSM

Alethea Capital Management Mercer Island, Washington $186M AUM 51.17% 1-Year Est. Return

Stifel Financial

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return